Concentras Parent ROA 2022-2025 | CON
Current and historical return on assets (ROA) values for Concentras Parent (CON) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Concentras Parent ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $0.16B | $2.73B | 6.22% |
| 2024-12-31 | $0.17B | $2.52B | 9.07% |
| 2024-06-30 | $0.15B | $2.36B | 26.07% |
| 2024-03-31 | $0.16B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.704B | $1.900B |
| Concentra Group Holdings Parent Inc. is a provider of occupational health services principally in the United States. Concentra Group Holdings Parent Inc. is based in MECHANICSBURG, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.092B | 26.27 |
| CVS Health (CVS) | United States | $84.870B | 10.55 |
| Elevance Health (ELV) | United States | $84.768B | 10.94 |
| Cencora (COR) | United States | $56.829B | 19.77 |
| Natera (NTRA) | United States | $22.878B | 0.00 |
| DiDi Global (DIDIY) | China | $22.356B | 23.75 |
| Labcorp Holdings (LH) | United States | $21.716B | 17.61 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.887B | 0.00 |
| Solventum (SOLV) | United States | $12.588B | 13.33 |
| CochLear (CHEOY) | Australia | $12.104B | 0.00 |
| ICON (ICLR) | Ireland | $11.456B | 10.65 |
| Revvity (RVTY) | United States | $11.099B | 19.10 |
| Doximity (DOCS) | United States | $10.990B | 50.88 |
| Viatris (VTRS) | United States | $10.281B | 3.53 |
| Avantor (AVTR) | United States | $8.961B | 13.02 |
| HealthEquity (HQY) | United States | $8.648B | 37.88 |
| Medpace Holdings (MEDP) | United States | $8.563B | 22.74 |
| Sonic Healthcare (SKHHY) | Australia | $8.268B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.124B | 13.96 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.096B | 24.12 |
| BrightSpring Health Services (BTSG) | United States | $3.753B | 34.44 |
| Sotera Health (SHC) | United States | $3.108B | 17.66 |
| Alignment Healthcare (ALHC) | United States | $2.883B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.605B | 33.88 |
| Organon (OGN) | United States | $2.561B | 2.72 |
| PACS (PACS) | United States | $1.882B | 0.00 |
| Progyny (PGNY) | United States | $1.846B | 40.62 |
| Premier (PINC) | United States | $1.832B | 13.91 |
| GeneDx Holdings (WGS) | United States | $1.827B | 70.37 |
| Ardent Health (ARDT) | United States | $1.818B | 7.75 |
| GoodRx Holdings (GDRX) | United States | $1.568B | 31.36 |
| Teladoc Health (TDOC) | United States | $1.242B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.152B | 8.76 |
| CareDx (CDNA) | United States | $1.087B | 16.97 |
| Establishment Labs Holdings (ESTA) | $1.082B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.869B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.842B | 7.88 |
| QDM (QDMI) | Hong Kong, SAR China | $0.758B | 0.00 |
| Nutex Health (NUTX) | United States | $0.642B | 9.71 |
| LifeMD (LFMD) | United States | $0.617B | 0.00 |
| Embecta (EMBC) | United States | $0.575B | 3.87 |
| InnovAge Holding (INNV) | United States | $0.505B | 0.00 |
| Enhabit (EHAB) | United States | $0.485B | 39.92 |
| Auna S.A (AUNA) | Luxembourg | $0.472B | 10.63 |
| SBC Medicals (SBC) | United States | $0.469B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.454B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.419B | 0.00 |
| Omada Health (OMDA) | $0.390B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.261B | 0.00 |
| Oncology Institute (TOI) | United States | $0.209B | 0.00 |
| Beauty Health (SKIN) | United States | $0.193B | 0.00 |
| DocGo (DCGO) | United States | $0.163B | 26.67 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.115B | 0.00 |
| So-Young (SY) | China | $0.104B | 0.00 |
| OncoCyte (OCX) | United States | $0.092B | 0.00 |
| KindlyMD (NAKA) | United States | $0.089B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.050B | 0.00 |
| ModivCare (MODV) | United States | $0.047B | 0.00 |
| Biodesix (BDSX) | United States | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.032B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |